{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T01:26:40Z","timestamp":1794274000335,"version":"4.9.0"},"reference-count":135,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,7,3]],"date-time":"2019-07-03T00:00:00Z","timestamp":1562112000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"DOI":"10.3389\/fneur.2019.00710","type":"journal-article","created":{"date-parts":[[2019,7,3]],"date-time":"2019-07-03T09:57:55Z","timestamp":1562147875000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":179,"title":["International Guidelines for the Treatment of Huntington's Disease"],"prefix":"10.3389","volume":"10","author":[{"given":"Anne-Catherine","family":"Bachoud-L\u00e9vi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joaquim","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renaud","family":"Massart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katia","family":"Youssov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Rosser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Busse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Craufurd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralf","family":"Reilmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"De Michele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Rae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ferdinando","family":"Squitieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus","family":"Seppi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Perrine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clarisse","family":"Scherer-Gagou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Audrey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Verny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Marc","family":"Burgunder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,7,3]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"CD006456","DOI":"10.1002\/14651858.CD006456.pub2","article-title":"Therapeutic interventions for symptomatic treatment in Huntington's disease","volume":"8","author":"Mestre","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"B2","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/S1474-4422(10)70245-3","article-title":"Huntington's disease: from molecular pathogenesis to clinical treatment","volume":"10","author":"Ross","year":"2011","journal-title":"Lancet Neurol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1002\/mds.23953","article-title":"Pharmacologic approaches to the treatment of Huntington's disease","volume":"27","author":"Venuto","year":"2012","journal-title":"Mov Disord"},{"key":"B4","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1212\/WNL.0b013e318263c443","article-title":"American Academy of Neurology. Evidence-based guideline: pharmacologic treatment of chorea in Huntington disease: report of the guideline development subcommittee of the American Academy of Neurology","volume":"79","author":"Armstrong","year":"2012","journal-title":"Neurology"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1002\/mds.26014","article-title":"Current therapeutic options for Huntington's disease: good clinical practice versus evidence-based approaches?","volume":"29","author":"Killoran","year":"2014","journal-title":"Mov Disord"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1788","DOI":"10.1002\/mds.22188","article-title":"A Europe-wide assessment of current medication choices in Huntington's disease","volume":"23","author":"Priller","year":"2008","journal-title":"Mov Disord"},{"key":"B7","doi-asserted-by":"publisher","first-page":"RRN1260","DOI":"10.1371\/currents.RRN1260","article-title":"An international survey-based algorithm for the pharmacologic treatment of chorea in Huntington's disease","volume":"3","author":"Burgunder","year":"2011","journal-title":"PLoS Curr"},{"key":"B8","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/B978-0-12-801893-4.00006-7","article-title":"Cognitive and behavioral changes in Huntington disease before diagnosis","volume":"144","author":"Paulsen","year":"2017","journal-title":"Handb Clin Neurol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1212\/01.wnl.0000198586.85250.13","article-title":"Tetrabenazine as antichorea therapy in Huntington disease: a randomized controlled trial","volume":"66","year":"2006","journal-title":"Neurology"},{"key":"B10","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1185\/03007998409109601","article-title":"Tiapride versus placebo: a double-blind comparative study in the management of Huntington's chorea","volume":"9","author":"Deroover","year":"1984","journal-title":"Curr Med Res Opin"},{"key":"B11","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1136\/jnnp.47.8.844","article-title":"A double blind trial of sulpiride in Huntington's disease and tardive dyskinesia","volume":"47","author":"Quinn","year":"1984","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1111\/ene.13349","article-title":"Clinical characterization of dystonia in adult patients with Huntington's disease","volume":"24","author":"van de Zande","year":"2017","journal-title":"Eur J Neurol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1016\/S0140-6736(69)90662-X","article-title":"L-dopa and juvenile Huntington's disease","volume":"2","author":"Barbeau","year":"1969","journal-title":"Lancet"},{"key":"B14","doi-asserted-by":"crossref","first-page":"393","DOI":"10.5694\/j.1326-5377.1974.tb47770.x","article-title":"Huntington's chorea: the rigid form (Westphal variant) treated with levodopa","volume":"1","author":"Low","year":"1974","journal-title":"Med J Aust"},{"key":"B15","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1136\/jnnp.68.2.238","article-title":"Late onset levodopa responsive Huntington's disease with minimal chorea masquerading as Parkinson plus syndrome","volume":"68","author":"Reuter","year":"2000","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B16","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1177\/08830738030180061301","article-title":"Unusual early-onset Huntingtons disease","volume":"18","author":"Vargas","year":"2003","journal-title":"J Child Neurol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/0303-8467(80)90017-7","article-title":"Seven cases of Huntington's disease in childhood and levodopa induced improvement in the hypokinetic\u2013rigid form","volume":"82","author":"Jongen","year":"1980","journal-title":"Clin Neurol Neurosurg"},{"key":"B18","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1002\/mds.20093","article-title":"Markedly asymmetrical parkinsonism as a leading feature of adult-onset Huntington's disease","volume":"19","author":"Wang","year":"2004","journal-title":"Mov Disord"},{"key":"B19","doi-asserted-by":"publisher","first-page":"21","DOI":"10.2217\/nmt.11.86","article-title":"Physiotherapy clinical guidelines for Huntington's disease","volume":"2","author":"Quinn","year":"2012","journal-title":"Neurodegener Dis Manage"},{"key":"B20","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/1471-2377-9-62","article-title":"Tetrabenazine as anti-chorea therapy in Huntington disease: an open-label continuation study. Huntington Study Group\/TETRA-HD Investigators","volume":"9","author":"Frank","year":"2009","journal-title":"BMC Neurol"},{"key":"B21","doi-asserted-by":"crossref","first-page":"583","DOI":"10.5694\/j.1326-5377.1976.tb140870.x","article-title":"Tetrabenazine in the treatment of Huntington's chorea","volume":"1","author":"Huang","year":"1976","journal-title":"Med J Aust"},{"key":"B22","doi-asserted-by":"publisher","first-page":"A58","DOI":"10.1136\/jnnp-2014-309032.165","article-title":"I03 swallowing function in the early, middle and late stages of Huntington's disease","volume":"85","author":"Monaco","year":"2014","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B23","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1007\/BF02493441","article-title":"Dysphagia in Huntington's disease: a 16-year retrospective","volume":"7","author":"Kagel","year":"1992","journal-title":"Dysphagia"},{"key":"B24","first-page":"1","article-title":"Home program of speech therapy in Huntington's disease","volume":"18","author":"Giddens","year":"2010","journal-title":"J Med Speech Lang Pathol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1002\/mds.870080216","article-title":"Adult onset myoclonic Huntington's disease","volume":"8","author":"Carella","year":"1993","journal-title":"Mov Disord"},{"key":"B26","first-page":"82","article-title":"Intention myoclonus in Huntington's disease","volume":"41","author":"Novom","year":"1976","journal-title":"Bull Los Angeles Neurol Soc"},{"key":"B27","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/BF02335850","article-title":"Myoclonus and Huntington's chorea: description of a case","volume":"1","author":"Previdi","year":"1980","journal-title":"Ital J Neurol Sci"},{"key":"B28","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/1471-2377-6-11","article-title":"Dose-dependent improvement of myoclonic hyperkinesia due to Valproic acid in eight Huntington's disease patients: a case series","volume":"6","author":"Saft","year":"2006","journal-title":"BMC Neurol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1002\/mds.870090609","article-title":"Cortical myoclonus in Huntington's disease","volume":"9","author":"Thompson","year":"1994","journal-title":"Mov Disord"},{"key":"B30","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1002\/ana.410290217","article-title":"Myoclonus in adult Huntington's disease","volume":"29","author":"Vogel","year":"1991","journal-title":"Ann Neurol."},{"key":"B31","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1684\/j.1950-6945.2003.tb00004.x","article-title":"EEG characteristics in juvenile Huntington's disease: a case report and review of the literature","volume":"5","author":"Landau","year":"2003","journal-title":"Epileptic Disord"},{"key":"B32","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1177\/155005948001100202","article-title":"Myoclonic and major seizures in early adult Huntington's chorea: case-report and electro-clinical findings","volume":"11","author":"Kereshi","year":"1980","journal-title":"Clin Electroencephalogr"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1002\/mds.21987","article-title":"Spectrum of gait impairments in presymptomatic and symptomatic Huntington's disease","volume":"23","author":"Rao","year":"2008","journal-title":"Mov Disord."},{"key":"B34","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.neucli.2008.01.003","article-title":"Evolution of locomotion disorders in Huntington's disease","volume":"38","author":"Delval","year":"2008","journal-title":"Neurophysiol Clin"},{"key":"B35","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1177\/0269215507075495","article-title":"Effects of an intensive rehabilitation programme on patients with Huntington's disease: a pilot study","volume":"21","author":"Zinzi","year":"2007","journal-title":"Clin Rehabil"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1371\/currents.hd.9504af71e0d1f87830c25c394be47027","article-title":"Effects of a one year intensive multidisciplinary rehabilitation program for patients with Huntington's disease: a prospective intervention study","author":"Piira","year":"2013","journal-title":"PLoS Curr"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1371\/currents.hd.2c56ceef7f9f8e239a59ecf2d94cddac","article-title":"Effects of a two-year intensive multidisciplinary rehabilitation program for patients with Huntington's disease: a prospective intervention study","author":"Piira","year":"2014","journal-title":"PLoS Curr"},{"key":"B38","doi-asserted-by":"publisher","first-page":"A40","DOI":"10.1136\/jnnp.2010.222661.4","article-title":"J04 The effect of video game-based exercise on dynamic balance and mobility in individuals with Huntington's disease","volume":"81","author":"Kegelmeyer","year":"2010","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B39","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1097\/NPT.0000000000000016","article-title":"A randomized feasibility study of a 12-week community-based exercise program for people with Huntington's disease","volume":"37","author":"Busse","year":"2013","journal-title":"J Neurol Phys Ther"},{"key":"B40","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.2522\/ptj.20140123","article-title":"Task-specific training in Huntington disease: a randomized controlled feasibility trial","volume":"94","author":"Quinn","year":"2014","journal-title":"Phys Ther."},{"key":"B41","first-page":"189","article-title":"Effectiveness of intensive neurorehabilitation in patients with Huntington's disease","volume":"49","author":"Ciancarelli","year":"2013","journal-title":"Eur J Phys Rehabil Med"},{"key":"B42","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1177\/0269215512473762","article-title":"What effect does a structured home-based exercise programme have on people with Huntington's disease?","volume":"27","author":"Khalil","year":"2013","journal-title":"Clin Rehabil"},{"key":"B43","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1002\/1531-8257(199909)14:5<808::AID-MDS1014>3.0.CO;2-J","article-title":"Velocity modulation and rhythmic synchronization of gait in Huntington's disease","volume":"14","author":"Thaut","year":"1999","journal-title":"Mov Disord."},{"key":"B44","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1111\/j.1468-1331.2012.03760.x","article-title":"Physical therapy in Huntington's disease\u2013toward objective assessments?","volume":"20","author":"Bohlen","year":"2013","journal-title":"Eur J Neurol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.pjnns.2015.09.002","article-title":"The effects of physiotherapy with PNF concept on gait and balance of patients with Huntington's disease - pilot study","volume":"49","author":"Mirek","year":"2015","journal-title":"Neurol Neurochir Pol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1097\/00002826-200209000-00007","article-title":"Olanzapine for Huntington's disease: an open label study","volume":"25","author":"Bonelli","year":"2002","journal-title":"Clin Neuropharmacol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1097\/00004850-200203000-00009","article-title":"High-dose olanzapine in Huntington's disease","volume":"17","author":"Bonelli","year":"2002","journal-title":"Int Clin Psychopharmacol"},{"key":"B48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2147\/NDT.S4165","article-title":"Aripiprazole in the treatment of Huntington's disease: a case series","volume":"5","author":"Ciammola","year":"2009","journal-title":"Neuropsychiatr Dis Treat"},{"key":"B49","first-page":"169","article-title":"Treatment of Huntington's chorea with sulpiride","volume":"79","author":"Knowling","year":"1991","journal-title":"S Afr Med J"},{"key":"B50","doi-asserted-by":"publisher","first-page":"e30903","DOI":"10.1371\/journal.pone.0030903","article-title":"The impact of different types of assistive devices on gait measures and safety in Huntington's disease","volume":"7","author":"Kloos","year":"2012","journal-title":"PLoS ONE"},{"key":"B51","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1176\/jnp.16.3.381-a","article-title":"Treatment of bruxism in Huntington's disease with botulinum toxin","volume":"16","author":"Nash","year":"2004","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"B52","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1002\/1531-8257(200001)15:1<171::AID-MDS1031>3.0.CO;2-Y","article-title":"Bruxism in Huntington's disease","volume":"15","author":"Tan","year":"2000","journal-title":"Mov Disord"},{"key":"B53","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/S0140-6736(74)92338-1","article-title":"A double-blind trial of tetrabenazine, thiopropazate, and placebo in patients with chorea","volume":"1","author":"McLellan","year":"1974","journal-title":"Lancet"},{"key":"B54","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1002\/mds.21920","article-title":"Patient and caregiver quality of life in Huntington's disease","volume":"23","author":"Ready","year":"2008","journal-title":"Mov Disord"},{"key":"B55","doi-asserted-by":"publisher","first-page":"e00312","DOI":"10.1002\/brb3.312","article-title":"The effect of multidisciplinary rehabilitation on brain structure and cognition in Huntington's disease: an exploratory study","volume":"5","author":"Cruickshank","year":"2015","journal-title":"Brain Behav"},{"key":"B56","doi-asserted-by":"publisher","first-page":"273","DOI":"10.3233\/JHD-140113","article-title":"Improved executive function and callosal white matter microstructure after rhythm exercise in Huntington's disease","volume":"3","author":"Metzler-Baddeley","year":"2014","journal-title":"J Huntingtons Dis"},{"key":"B57","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1002\/mds.25864","article-title":"The cognitive burden in Huntington's disease: pathology, phenotype, and mechanisms of compensation","volume":"29","author":"Papoutsi","year":"2014","journal-title":"Mov Disord."},{"key":"B58","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/0093-934X(87)90124-6","article-title":"Speech timing in Parkinson's and Huntington's disease","volume":"32","author":"Ludlow","year":"1987","journal-title":"Brain Lang"},{"key":"B59","doi-asserted-by":"publisher","first-page":"656","DOI":"10.3109\/13682820903494742","article-title":"Comprehension of complex discourse in different stages of Huntington's disease","volume":"45","author":"Saldert","year":"2010","journal-title":"Int J Lang Commun Disord."},{"key":"B60","doi-asserted-by":"publisher","first-page":"523","DOI":"10.3109\/13682820903222809","article-title":"Using talking mats to support communication in persons with Huntington's disease","volume":"45","author":"Ferm","year":"2010","journal-title":"Int J Lang Commun Disord"},{"key":"B61","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.bbr.2015.10.001","article-title":"Social cognition in Huntington's disease: a meta-analysis","volume":"297","author":"Bora","year":"2016","journal-title":"Behav Brain Res"},{"key":"B62","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1093\/arclin\/acq038","article-title":"Episodic memory in dementia: characteristics of new learning that differentiate Alzheimer's, Huntington's, and Parkinson's diseases","volume":"25","author":"Aretouli","year":"2010","journal-title":"Arch Clin Neuropsychol"},{"key":"B63","doi-asserted-by":"publisher","first-page":"e1263","DOI":"10.1371\/journal.pone.0001263","article-title":"Time processing in Huntington's disease: a group-control study","volume":"2","author":"Beste","year":"2007","journal-title":"PLoS ONE"},{"key":"B64","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.1002\/mds.25998","article-title":"Variability in interval production is due to timing-dependent deficits in Huntington's disease","volume":"29","author":"Rao","year":"2014","journal-title":"Mov Disord"},{"key":"B65","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.neuropsychologia.2013.09.039","article-title":"The basal ganglia in perceptual timing: timing performance in Multiple System Atrophy and Huntington's disease","volume":"52","author":"Cope","year":"2014","journal-title":"Neuropsychologia."},{"key":"B66","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1093\/brain\/123.7.1349","article-title":"Visual object and visuospatial cognition in Huntington's disease: implications for information processing in corticostriatal circuits","volume":"123","author":"Lawrence","year":"2000","journal-title":"Brain"},{"key":"B67","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.parkreldis.2016.02.008","article-title":"Neuropsychiatric symptoms are very common in premanifest and early stage Huntington's disease","volume":"25","author":"Martinez-Horta","year":"2016","journal-title":"Parkinsonism Relat Disord"},{"key":"B68","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1136\/jnnp-2013-307343","article-title":"Neuropsychiatric symptoms in a European Huntington's disease cohort (REGISTRY)","volume":"85","author":"van Duijn","year":"2014","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"B69","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1016\/j.jpsychires.2013.05.026","article-title":"Characterization of depression in prodromal Huntington disease in the neurobiological predictors of HD (PREDICT-HD) study","volume":"47","author":"Epping","year":"2013","journal-title":"J Psychiatr Res"},{"key":"B70","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1002\/mds.25750","article-title":"Results of the citalopram to enhance cognition in Huntington disease trial","volume":"29","author":"Beglinger","year":"2014","journal-title":"Mov Disord."},{"key":"B71","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1176\/jnp.8.2.209","article-title":"ECT in genetically confirmed Huntington's disease","volume":"8","author":"Lewis","year":"1996","journal-title":"J Neuropsychiatry Clin Neurosci."},{"key":"B72","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1176\/jnp.6.2.154","article-title":"ECT as a treatment for depression in Huntington's disease","volume":"6","author":"Ranen","year":"1994","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"B73","first-page":"145","article-title":"ECT in the treatment of organic psychosis in Huntington's disease","volume":"3","author":"Evans","year":"1987","journal-title":"Convuls Ther"},{"key":"B74","doi-asserted-by":"publisher","first-page":"239","DOI":"10.3233\/JHD-180299","article-title":"Suicidal ideation assessment in individuals with premanifest and manifest Huntington disease","volume":"7","author":"Wesson","year":"2018","journal-title":"J Huntingtons Dis"},{"key":"B75","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1159\/000327754","article-title":"PREDICT-HD Investigators of the Huntington Study Group. Suicidal behavior in prodromal Huntington disease","volume":"8","author":"Fiedorowicz","year":"2011","journal-title":"Neurodegener Dis"},{"key":"B76","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1176\/jnp.2007.19.4.441","article-title":"Psychopathology in verified Huntington's disease gene carriers","volume":"19","author":"van Duijn","year":"2007","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"B77","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1176\/jnp.8.3.338","article-title":"Sertraline in the treatment of severe aggressiveness in Huntington's disease","volume":"8","author":"Ranen","year":"1996","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"B78","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1007\/s002130000575","article-title":"Fluoxetine in the treatment of Huntington's disease","volume":"153","author":"De Marchi","year":"2001","journal-title":"Psychopharmacology (Berl)."},{"key":"B79","doi-asserted-by":"publisher","first-page":"e85430","DOI":"10.1371\/journal.pone.0085430","article-title":"Effectiveness of anti-psychotics and related drugs in the Huntington French-speaking group cohort","volume":"9","author":"D\u00e9sam\u00e9ricq","year":"2014","journal-title":"PLoS ONE"},{"key":"B80","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1212\/WNL.45.5.1023","article-title":"Clozapine in Huntington's disease","volume":"45","author":"Colosimo","year":"1995","journal-title":"Neurology."},{"key":"B81","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1097\/YIC.0b013e3283407775","article-title":"Risperidone long-acting injection and Huntington's disease: case series with significant psychiatric and behavioural symptoms","volume":"26","author":"Johnston","year":"2011","journal-title":"Int Clin Psychopharmacol"},{"key":"B82","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1056\/NEJM200009283431316","article-title":"Improvement of Huntington's disease with olanzapine and valproate","volume":"343","author":"Grove","year":"2000","journal-title":"N Engl J Med"},{"key":"B83","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1080\/15622970701332520","article-title":"Lamotrigine in motor and mood symptoms of Huntington's disease","volume":"9","author":"Shen","year":"2008","journal-title":"World J Biol Psychiatry"},{"key":"B84","doi-asserted-by":"publisher","first-page":"VII54","DOI":"10.1007\/s00415-006-7012-5","article-title":"Apathy and the basal ganglia","volume":"253","author":"Levy","year":"2006","journal-title":"J Neurol"},{"key":"B85","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1176\/appi.neuropsych.14030051","article-title":"Irritability in a prospective cohort of Huntington's disease mutation carriers","volume":"27","author":"Bouwens","year":"2015","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"B86","first-page":"69","article-title":"Short-term effects of olanzapine in Huntington disease","volume":"14","author":"Squitieri","year":"2001","journal-title":"Neuropsychiatry Neuropsychol Behav Neurol"},{"key":"B87","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/10401230701844802","article-title":"Risperidone and the treatment of psychiatric, motor, and cognitive symptoms in Huntington's disease","volume":"20","author":"Duff","year":"2008","journal-title":"Ann Clin Psychiatry"},{"key":"B88","doi-asserted-by":"publisher","first-page":"159","DOI":"10.3233\/JHD-130051","article-title":"Quality of life in Huntington's disease: a comparative study investigating the impact for those with pre-manifest and early manifest disease, and their partners","volume":"2","author":"Read","year":"2013","journal-title":"J Huntingtons Dis"},{"key":"B89","first-page":"216","article-title":"Obsessive compulsive disorder in huntington disease: a case of isolated obsessions successfully treated with sertraline","volume":"15","author":"Patzold","year":"2002","journal-title":"Neuropsychiatry Neuropsychol Behav Neurol"},{"key":"B90","first-page":"e131","article-title":"Hypersexual features in Huntington's disease","volume":"52","author":"Jhanjee","year":"2011","journal-title":"Singapore Med J"},{"key":"B91","doi-asserted-by":"publisher","first-page":"1994","DOI":"10.1016\/j.pnpbp.2008.07.010","article-title":"Cyproterone for treatment of hypersexuality in an elderly Huntington's disease patient","volume":"32","author":"Tavares","year":"2008","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"B92","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1002\/mds.870090317","article-title":"Leuprolide acetate for exhibitionism in Huntington's disease","volume":"9","author":"Rich","year":"1994","journal-title":"Mov Disord"},{"key":"B93","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1176\/appi.ajp.158.12.1966","article-title":"Successful multimodality treatment of severe behavioral disturbance in a patient with advanced Huntington's disease","volume":"158","author":"Blass","year":"2001","journal-title":"Am J Psychiatry"},{"key":"B94","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1034\/j.1600-0404.2002.01197.x","article-title":"Olanzapine in Huntington's disease","volume":"105","author":"Paleacu","year":"2002","journal-title":"Acta Neurol Scand"},{"key":"B95","first-page":"1353","article-title":"Clinical experience with risperidone and memantine in the treatment of Huntington's disease","volume":"98","author":"Cankurtaran","year":"2006","journal-title":"J Natl Med Assoc"},{"key":"B96","doi-asserted-by":"publisher","first-page":"117","DOI":"10.3109\/10401239809148945","article-title":"Psychiatric and neuropsychological abnormalities in Huntington's disease: a case study","volume":"10","author":"Madhusoodanan","year":"1998","journal-title":"Ann Clin Psychiatry"},{"key":"B97","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1097\/00019442-199800640-00013","article-title":"Use of risperidone in psychosis associated with Huntington's disease","volume":"6","author":"Madhusoodanan","year":"1998","journal-title":"Am J Geriatr Psychiatry"},{"key":"B98","doi-asserted-by":"publisher","first-page":"e4","DOI":"10.1176\/jnp.2010.22.3.352.e4","article-title":"Aripiprazole in the treatment of olanzapine-resistant psychotic and motor symptoms of Huntington's disease","volume":"22","author":"Oulis","year":"2010","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"B99","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1097\/00004714-199704000-00023","article-title":"Risperidone in treatment of choreoathetosis of Huntington's disease","volume":"17","author":"Parsa","year":"1997","journal-title":"J Clin Psychopharmacol"},{"key":"B100","first-page":"169","article-title":"Efficacy of clozapine in the course of Huntington chorea: apropos of a clinical case","volume":"27","author":"Vallette","year":"2001","journal-title":"Encephale"},{"key":"B101","doi-asserted-by":"publisher","first-page":"E31","DOI":"10.1176\/appi.neuropsych.12040097","article-title":"Aripiprazole treatment for choreoathetoid and psychotic symptoms of Huntington's disease","volume":"25","author":"Yavuz","year":"2013","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"B102","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1176\/appi.psy.47.1.70","article-title":"Quetiapine in the treatment of behavioral disturbances in patients with Huntington's disease","volume":"47","author":"Alpay","year":"2006","journal-title":"Psychosomatics"},{"key":"B103","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1177\/070674370404900617","article-title":"Quetiapine in the management of psychosis secondary to huntington's disease: a case report","volume":"49","author":"Seitz","year":"2004","journal-title":"Can J Psychiatry"},{"key":"B104","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1097\/YIC.0b013e328361e145","article-title":"Treatment of psychotic and behavioral symptoms with clozapine, aripiprazole, and reboxetine in a patient with Huntington's disease","volume":"28","author":"Edlinger","year":"2013","journal-title":"Int Clin Psychopharmacol"},{"key":"B105","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1212\/WNL.41.1.156","article-title":"Clozapine treatment of psychiatric symptoms resistant to neuroleptic treatment in patients with Huntington's chorea","volume":"41","author":"Sajatovic","year":"1991","journal-title":"Neurology"},{"key":"B106","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1176\/appi.ajp.2008.08040503","article-title":"Aripiprazole effects on psychosis and chorea in a patient with Huntington's disease","volume":"165","author":"Lin","year":"2008","journal-title":"Am J Psychiatry."},{"key":"B107","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1007\/s00415-012-6720-2","article-title":"Modified electroconvulsive therapy for the treatment of refractory schizophrenia-like psychosis associated with Huntington's disease","volume":"260","author":"Nakano","year":"2013","journal-title":"J Neurol"},{"key":"B108","doi-asserted-by":"publisher","first-page":"E33","DOI":"10.1176\/appi.neuropsych.12070164","article-title":"Experience with intramuscular zuclopenthixol and medroxyprogesterone acetate in the treatment of agitation and aggression in Huntington's disease","volume":"25","author":"Rej","year":"2013","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"B109","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/BF01573339","article-title":"Drug treatment in 117 cases of Huntington's disease with special reference to fluphenazine (Prolixin)","volume":"41","author":"Korenyi","year":"1967","journal-title":"Psychiatr Q"},{"key":"B110","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.parkreldis.2017.09.013","article-title":"Circadian rhythm and autonomic dysfunction in presymptomatic and early Huntington's disease","volume":"44","author":"Bellosta Diago","year":"2017","journal-title":"Parkinsonism Relat Disord"},{"key":"B111","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1001\/archneur.65.4.482","article-title":"Rapid eye movement sleep disturbances in Huntington disease","volume":"65","author":"Arnulf","year":"2008","journal-title":"Arch Neurol"},{"key":"B112","doi-asserted-by":"publisher","first-page":"1934","DOI":"10.1212\/WNL.55.12.1934","article-title":"Efficiency of carbamazepine in the treatment of micturitional disturbances in Huntington disease","volume":"55","author":"Cochen","year":"2000","journal-title":"Neurology"},{"key":"B113","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1038\/sj.bdj.2008.803","article-title":"Access to special care dentistry, part 7. Special care dentistry services: seamless care for people in their middle years\u2013part 1","volume":"205","author":"Lewis","year":"2008","journal-title":"Br Dent J"},{"key":"B114","doi-asserted-by":"publisher","first-page":"55","DOI":"10.2217\/nmt.11.68","article-title":"Guideline for oral healthcare of adults with Huntington's disease","volume":"2","author":"Manley","year":"2012","journal-title":"Neurodegener Dis Manag"},{"key":"B115","doi-asserted-by":"publisher","first-page":"333","DOI":"10.12968\/denu.2008.35.5.333","article-title":"Providing dental care for patients with Huntington's disease","volume":"35","author":"Boyle","year":"2008","journal-title":"Dent Update"},{"key":"B116","first-page":"131","article-title":"Huntington's chorea: review and case report","volume":"33","author":"Moline","year":"1985","journal-title":"Gen Dent"},{"key":"B117","first-page":"150","article-title":"Huntington's disease: review and anesthetic case management","volume":"45","author":"Cangemi","year":"1998","journal-title":"Anesth Prog"},{"key":"B118","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.parkreldis.2016.10.017","article-title":"Early enteric neuron dysfunction in mouse and human Huntington disease","volume":"34","author":"Sciacca","year":"2017","journal-title":"Parkinsonism Relat Disord."},{"key":"B119","doi-asserted-by":"publisher","first-page":"33","DOI":"10.2217\/nmt.11.69","article-title":"Nutritional management of individuals with Huntington's disease: nutritional guidelines","volume":"2","author":"Brotherton","year":"2012","journal-title":"Neurodegener Dis Manage"},{"key":"B120","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.nut.2003.10.007","article-title":"Assessment of the nutrition status of patients with Huntington's disease","volume":"20","author":"Trejo","year":"2004","journal-title":"Nutrition"},{"key":"B121","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1212\/01.wnl.0000238106.10423.00","article-title":"Effect of donepezil on motor and cognitive function in Huntington disease","volume":"67","author":"Cubo","year":"2006","journal-title":"Neurology"},{"key":"B122","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1001\/archneur.1985.04060010063017","article-title":"Dysphagia in Huntington's disease","volume":"42","author":"Leopold","year":"1985","journal-title":"Arch Neurol"},{"key":"B123","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1002\/mds.870110509","article-title":"Characteristics of individuals with Huntington disease in long-term care","volume":"11","author":"Nance","year":"1996","journal-title":"Mov Disord"},{"key":"B124","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/j.nut.2004.12.012","article-title":"Use of oral nutritional supplements in patients with Huntington's disease","volume":"21","author":"Trejo","year":"2005","journal-title":"Nutrition"},{"key":"B125","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1530\/eje.0.1510451","article-title":"Circulating and cerebrospinal fluid ghrelin and leptin: potential role in altered body weight in Huntington's disease","volume":"151","author":"Popovic","year":"2004","journal-title":"Eur J Endocrinol"},{"key":"B126","doi-asserted-by":"publisher","first-page":"A69","DOI":"10.1136\/jnnp-2014-309032.197","article-title":"J14 mediterranean diet and nutritional composition of patients with Huntington's disease. Spanish multicenter study of the European group for Huntington's disease","volume":"85","author":"Rivadeneyra","year":"2014","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B127","first-page":"78","article-title":"The relationship between dietary intake, nutrition status and Huntington's disease severity (P1.050)","volume":"4","author":"Cubo","year":"2014","journal-title":"Neurology"},{"key":"B128","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1177\/0269215514564087","article-title":"Respiratory muscle training on pulmonary and swallowing function in patients with Huntington's disease: a pilot randomised controlled trial","volume":"29","author":"Reyes","year":"2015","journal-title":"Clin Rehabil"},{"key":"B129","doi-asserted-by":"publisher","first-page":"313","DOI":"10.2147\/DDDT.S138828","article-title":"Review of deutetrabenazine: a novel treatment for chorea associated with Huntington's disease","volume":"12","author":"Dean","year":"2018","journal-title":"Drug Des Devel Ther"},{"key":"B130","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1001\/jama.2016.8011","article-title":"Effect of deutetrabenazine on chorea among patients with Huntington disease: a randomized clinical trial","volume":"316","author":"Frank","year":"2016","journal-title":"JAMA"},{"key":"B131","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1093\/ptj\/pzx031","article-title":"Physical activity self-management and coaching compared to social interaction in Huntington disease: results from the ENGAGE-HD randomized, controlled pilot feasibility trial","volume":"97","author":"Busse","year":"2017","journal-title":"Phys Ther"},{"key":"B132","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1007\/s00415-016-8310-1","article-title":"Exercise effects in Huntington disease","volume":"264","author":"Frese","year":"2017","journal-title":"J Neurol"},{"key":"B133","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1186\/s13023-017-0740-z","article-title":"Effects of endurance training on skeletal muscle mitochondrial function in Huntington disease patients","volume":"12","author":"Mueller","year":"2017","journal-title":"Orphanet J Rare Dis"},{"key":"B134","doi-asserted-by":"publisher","first-page":"ecurrents","DOI":"10.1371\/currents.hd.cba6ea74972cf8412a73ce52eb018c1e","article-title":"Is there an association of physical activity with brain volume, behavior, and day-to-day functioning?","volume":"8","author":"Wallace","year":"2016","journal-title":"PLoS Curr"},{"key":"B135","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1097\/NPT.0000000000000188","article-title":"Members of the Physiotherapy Working Group of the European Huntington's Disease Network. A classification system to guide physical therapy management in huntington disease: a case series","volume":"41","author":"Fritz","year":"2017","journal-title":"J Neurol Phys Ther."}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fneur.2019.00710\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,20]],"date-time":"2024-07-20T11:48:56Z","timestamp":1721476136000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fneur.2019.00710\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,3]]},"references-count":135,"alternative-id":["10.3389\/fneur.2019.00710"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2019.00710","relation":{"has-part":[{"id-type":"doi","id":"https:\/\/doi.org\/10.3389\/fneur.2019.00710.s001","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.3389\/fneur.2019.00710.s002","asserted-by":"subject"}]},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,3]]},"article-number":"710"}}